actelion ltd-reg (ATLN:SIX Swiss Ex)
Elias Adam Zerhouni M.D.
President of Global Research & Development at Sanofi-aventis, Actelion Ltd.
|Age||Total Calculated Compensation||This person is connected to 103 board members in 6 different organizations across 6 different industries.|
See Board Relationships
Dr. Elias Adam Zerhouni, M.D has been the President of Global Research and Development at Sanofi since January 2011. Dr. Zerhouni serves as a Consultant. He serves as Senior Advisor of Johns Hopkins University School of Medicine. He served as Managing Director and President of Global R&D Medicines & Vaccines of Sanofi-aventis (now Sanof). He served as a Principal Investigator on three NIH grants and Co-investigator on two others. He served as a Consultant to the World ...
Gewerberstrasse 16Phone: 41 61 565 65 65
Allschwil, Basel-Landschaft 4123
Fax: 41 61 565 65 00
Board Members Memberships*
Emeritus Public Trustee
Member of Board of Trustees
President of Global Research & Development at Sanofi-aventis
Director and Member of Nominating & Governance Committee
Bachelor's Degree 1975
University Of Algiers
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jean-Jacques Bienaimé||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Martine A. Rothblatt Ph.D., MBA, J.D.||Founder, Chairman and Chief Executive Officer|
United Therapeutics Corporation
|Marc M.P. de Garidel||Chairman, Chief Executive Officer and Member of Strategic Committee|
|Frederic Roch Doliveux DVM||Chief Executive Officer and Executive Director|
|Jörg-Thomas Dierks||Chief Executive Officer|
|kr2.1M||Compensation as of Fiscal Year 2013.|